Joff Masukawa is founder of Diligentia Strategy, a life-sciences consultancy specializing in development of commercial strategies and tactical plans for manufacturers of rare orphan and specialty drugs, cell and gene therapies, digital therapeutics and other emerging medical innovations. Diligentia also offers government relations and public affairs services to facilitate client business priorities with policymakers and government agencies.
Prior to founding Diligentia, Joff was Vice President and Global Head of Government Relations and Public Affairs at Shire, where he designed and led strategies to build the company’s brand, engagement and leadership with government representatives and agencies, patient advocacy groups, industry associations and other key external stakeholders.
Joff has held senior level leadership roles spanning commercial and corporate functions, including commercial strategy, government and public affairs, market access, patient advocacy, and sales and sales management at Shire, Genzyme, and Visible Genetics. He has developed and executed many commercial launch strategies for innovative products and is adept at aligning optimal legislative, regulatory and market access solutions to support business objectives. He began his career as a clinical sales representative for Merck. Joff is a board member of Americas Health Foundation. He holds BA in International Studies from Johns Hopkins University, an executive certificate in Strategic Communications from Columbia University, and has completed graduate studies in International Affairs at the Johns Hopkins School of International Studies.
